Leads scientific research and various high impact partnerships for nference. An alumni and Postdoctoral Fellow of Stanford University with a Ph.D. in Computational Biology from the university of Cambridge. Worked as an investigator for Novartis Institutes for BioMedical Research (NIBR) prior to joining nference.
Reimagining Biomedicine in the Age of AI
Deep learning tools can analyze medical images with greater accuracy than the human eye. This is particularly relevant in fields such as radiology pathology, where AI can help identify anomalies in PET scans, and MRIs and biopsy slides, contributing significantly to the early detection of diseases or treatment pathways.
AI and Data Sciences Showcase:
nference partners with health systems to transform decades of rich and predominantly unstructured data captured in EMR into powerful software solutions that enable scientists to discover and develop personalized dx and treatments for patients worldwide.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.